Résultats de la recherche - 5 results

Vaccine effectiveness against COVID-19 hospitalisation in adults (≥ 20 years) during Alpha- and Delta-dominant circulation: I-MOVE-COVID-19 and VEBIS SARI VE networks, Europe, 2021

Patricia CJL; Gomez, Verónica; Lesieur, Zineb; Barbezange, Cyril; van Nedervelde, Els; Borg, Maria-Louise; Castilla, Jesús; Lazar, Mihaela; O’Donnell, Joan; Jonikaite, Indrė; Demlová, Regina; Amerali, ...

Mycoplasma pneumoniae: delayed re-emergence after COVID-19 pandemic restrictions.

https://sciensano.be/en/10.1016/S2666-5247%2823%2900344-0 Version:  Published Full text language:  English Category:  Peer-reviewed scientific articles FOS Classification:  3 MEDICAL AND HEALTH SCIENCES ...

Seasonal and inter-seasonal RSV activity in the European Region during the COVID-19 pandemic from autumn 2020 to summer 2022.

Dimitrijevic, Dragana; Druc, Alina; Apostol, Mariana; Kalasnikova, Kate Karolina; Nikisins, Sergejs; Reiche, Janine; Cai, Wei; Meijer, Adam; Teirlinck, Anne; Larrauri, Amparo; Casas, Inmaculada; Enouf, Vincent; ...

Vaccine effectiveness against COVID-19 hospitalisation in adults (≥ 20 years) during Omicron-dominant circulation: I-MOVE-COVID-19 and VEBIS SARI VE networks, Europe, 2021 to 2022.

SARS-CoV-2 was 43% (95%  CI: 29-54) for complete PSV (with last dose received ≥ 150 days before onset), while it was 59% (95%  CI: 51-66) after addition of one booster dose. The VE was 85% (95%  CI: 78-89), ...

QR code

QR code for this page URL